.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,212,791

« Back to Dashboard

Details for Patent: 6,212,791

Title: Method of applying indicia to a fast-dissolving dosage form
Abstract:The invention permits the application of an identifying mark onto a fast-dissolving dosage form without the need for application of pressure or printing directly onto the dosage unit. The invention comprises preparing of a fast-dissolving dosage unit that is embossed with an identifying mark such as a manufacturer's logo, medicinal component strength, or other information relating to the unit. The desired identifying mark is first embossed onto the base of the container such as a blister pocket. Liquid suspension is then filled into the container and solidified, e.g., freeze-dried, therein. The resulting dosage unit in the container is thereby embossed with a substantial copy of the identifying mark that was embossed on the base of the container. The embossed identifying mark on the base of the container remains thereon as well thereby affording the ability to learn the identifying mark on the enclosed unit without opening the packet.
Inventor(s): Thompson; Andrew R. (Swindon, GB), Yarwood; Richard J. (Collingbourne Kingston, GB), Kearney; Patrick (Swindon, GB)
Assignee: R.P. Scherer Corporation (Paradise Valley, NV)
Filing Date:Mar 31, 2000
Application Number:09/541,156
Claims:1. A method for applying an identifying mark to a fast-dissolving dosage form comprising:

forming a blister pocket having at least one generally continuous blister pocket surface bearing an identifying embossment, said identifying embossment being discernible from said generally continuous blister pocket surface and representing a dosage identifying mark; and

forming said fast-dissolving dosage form directly in said blister pocket such that said fast-dissolving dosage form includes a generally continuous dosage surface corresponding to said generally continuous blister pocket surface and tactile embossed identifying mark thereon corresponding to said identifying embossment,

wherein forming said fast-dissolving dosage form comprises a process selected from the group consisting of a solid-state dissolution process, a vacuum drying process above collapse temperature, a hydrated gel or foam desiccation process and a sugar admixture and drying process.

2. The method according to claim 1, wherein forming said fast-dissolving dosage form comprises a solid-state dissolution process.

3. The method according to claim 2 wherein the solid-state dissolution process comprises the Gole Process.

4. The method according to claim 1, wherein forming said fast-dissolving dosage form comprises a vacuum drying process above collapse temperature.

5. The method according to claim 4, wherein the vacuum drying process above collapse temperature comprises the Pebley Process.

6. The method according to claim 1, wherein forming said fast-dissolving dosage form comprises a hydrated gel or foam desiccation process.

7. The method according to claim 6, wherein the hydrated gel or foam desiccation process comprises the Ecanow Process.

8. The method according to claim 1, wherein forming said fast-dissolving dosage form comprises a sugar admixture and drying process.

9. The method according to claim 8, wherein the sugar admixture and drying process comprises the Yamanouchi Process.

10. The method according to claim 1, wherein said tactile embossed identifying mark is an elevated identifying mark.

11. The method according to claim 1, wherein said tactile embossed identifying mark is a depressed identifying mark.

12. The method according to claim 1, wherein the step of forming said blister pocket comprises thermoforming.

13. The method according to claim 1, wherein the step of forming said blister pocket comprises cold-forming.

14. The method according to claim 1, wherein said blister pocket comprises aluminum laminate.

15. The method according to claim 1, wherein said blister pocket comprises plastic laminate.

16. The method according to claim 1, wherein said dosage identifying mark comprises indicia of component strength of said fast-dissolving dosage form.

17. The method according to claim 1, wherein said dosage identifying mark comprises indicia of a manufacturer of said fast-dissolving dosage form.

18. A fast-dissolving dosage form bearing an embossed identifying mark applied by the process of claim 1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc